3.8
4.5 
4.0 
3.8 
4.2 3.3
3.4 3.3 3.7 3.7 PERSONAL SPECIALTY: Life Sciences
FIRM DESCRIPTION: Investor Growth Capital (IGC) is a global expansion-stage venture capital firm with approximately $1.8 billion under management. IGC's North American offices were founded in 1995 in New York City and Menlo Park. The firm's team invests in high-quality, growth-oriented companies, primarily in the information technology and healthcare industries. The firm also has offices in Beijing, Hong Kong, Tokyo, and Stockholm and employs over 30 investment professionals worldwide. IGC often taps its global network to aid its companies in foreign partnerships and global expansion plans. Since inception, IGC's worldwide offices have partnered with over 100 companies, and a few of the firm's most successful investments include, Kyphon, B2, Jones Pharmaceuticals, Navini, Picolight, Stepstone, and Tessera. Investor Growth Capital is the wholly owned venture capital arm of Investor AB, a diversified Swedish investment company with a $28 billion net asset value. All of IGC's capital is provided by Investor AB through an evergreen fund structure. As a result, IGC does not manage a base of limited partners, has no fixed timeline for returning capital to its funding source and has no cross-fund issues. This structure allows its investment professionals to maximize time spent with their portfolio companies and to take a more flexible and often more patient, approach in managing the full portfolio company life-cycle.
Pitched Liza Page Nelson, she asked good questions and was very courteous and professional. Passed, but we felt respected which is more than I can say for many others.
PRIVATE: Members Only
